发明名称 |
MODULATION SAPP, SAPP ALPHA AND BDNF LEVELS IN INDIVIDUALS DIAGNOSED WITH FXS AND ASD |
摘要 |
A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting the amount of a therapeutic compound according to the plasma levels of BDNF, sAPP and sAPPs. In one embodiment, the therapeutic compound is acamprosate. |
申请公布号 |
EP2875355(A4) |
申请公布日期 |
2016.08.03 |
申请号 |
EP20130823641 |
申请日期 |
2013.07.22 |
申请人 |
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION |
发明人 |
ERICKSON, CRAIG, A.;LAHIRI, DEBOMOY, K. |
分类号 |
G01N33/53;A01N37/18;A01N43/54;A01N45/00;A61K31/185;A61K31/35;A61P43/00;G01N33/68 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|